Table 1 Patients’ clinical characteristics.
From: Effect of Lactobacillus delbrueckii subsp. lactis on vaginal radiotherapy for gynecological cancer
Control group (n = 26) | L.del intervention group (n = 28) | P value | |
|---|---|---|---|
Age (years, mean ± sd) | 55.9 (± 9.9) | 55.0 (± 7.8) | 0.727 |
With tumor (n, %) | 12 (46.2%) | 7 (25.0%) | 0.110 |
FIGO stagea (n, %) | 0.836 | ||
I | 8 (30.8%) | 9 (34.6%) | |
II | 11 (42.3%) | 7 (26.9%) | |
III | 7 (26.9%) | 10 (38.5%) | |
Others | 0 (0.0%) | 2 (7.7%) | |
Candida vaginosis (n, %) | 0 | 0 | – |
Trichomonas (n, %) | 0 | 0 | – |
Bacterial vaginitis (n, %) | 0 | 0 | – |
External beam radiotherapy dose (Gy, mean ± sd) | 47.2 (± 4.6) | 46.7 (± 5.1) | 0.709 |
Vaginal brachytherapy dose (Gy, mean ± sd) | 19.0 (± 9.7) | 15.9 (± 8.5) | 0.187 |
Total radiation dose (Gy, mean ± sd) | 66.2 (± 12.7) | 62.6 (± 11.9) | 0.286 |
Radiation injury level (post-treatment) | 1.23 (± 0.43) | 1.11 (± 0.31) | 0.237 |
△Vaginal secretions pH (mean ± sem) | 0.008 (± 0.057) | 0.029 (± 0.075) | 0.826 |
△Vaginal cleanliness (mean ± sem) | 0.000 (± 0.124) | − 0.036 (± 0.209) | 0.886 |
